Scientists say you can now use Osimertinib -a cancer drug- just once a week instead of daily and still be safe from tumour regrowths.
On 17th January 2025, Satya Nadella, Microsoft's Chairman and CEO, took to X to announce a research paper published in Nature that caught our attention.